Company

ADMA Biologics, Inc.

Headquarters: Ramsey, NJ, United States

Employees: 527

CEO: Mr. Adam S. Grossman

NASDAQ: ADMA +3.59%

Market Cap

$2.66 Billion

USD as of July 1, 2024

Market Cap History

ADMA Biologics, Inc. market capitalization over time

Evolution of ADMA Biologics, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of ADMA Biologics, Inc.

Detailed Description

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

ADMA Biologics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ADMA wb_incandescent

Details

Headquarters:

465 State Route 17

Ramsey, NJ 07446

United States

Phone: 201 478 5552

Fax: 201 478 5553